As per the latest report by IMARC Group, titled “Orthobiologics Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027”, The global orthobiologics market price reached US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2027, exhibiting a growth rate (CAGR) of 5.27% during 2022-2027....

Orthobiologics Market size was valued at USD 8.56 billion in 2022 and is expected to reach USD 13.20 billion By 2030 and grow at a CAGR of 5.6% over the forecast period of 2023-2030. This dynamic growth is fueled by a paradigm shift in healthcare, embracing the potential of orthobiologics to stimulate the body's natural healing mechanisms and offer minimally invasive solutions for a wide range...

Orthobiologics are derived from the human body and used by surgeons for treating injuries. It helps in easy recovery and healing of wounds. It can be useful for treating broken bones and injured muscles, tendons, and ligaments. The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are...

The Orthobiologics market is transforming the field of orthopedic treatments by offering advanced solutions for bone and tissue healing. With the rising number of sports injuries, aging population, and the growing adoption of minimally invasive surgeries, the demand for orthobiologics is increasing significantly. This article outlines the market trends, segmentation, key growth...